US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

OPTIMI HEALTH CORP.

4.90

-0.1700-3.35%

Post-market: 4.990.0900+1.84%19:47 EDT

Volume:59.77K

Turnover:293.56K

Market Cap:28.06M

PE:-3.52

High:5.10

Open:5.10

Low:4.76

Close:5.07

52wk High:8.84

52wk Low:4.00

Shares:5.73M

Float Shares:4.26M

Volume Ratio:0.46

T/O Rate:1.40%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.3932

EPS(LYR):-0.8329

ROE:-54.36%

ROA:-16.06%

PB:2.23

PE(LYR):-5.88

Loading ...

Overview Company News Filings

Optimi Health to Start Phase 2 Trial of Psilocybin-Assisted Therapy for Major Depressive Disorder in H1 2027

MT Newswires Live

Optimi Health to initiate Phase 2 trial of psilocybin-assisted therapy for MDD

Optimi Health establishes discretionary equity facility

Optimi Health Establishes Discretionary Equity Facility

Optimi Health completes psilocybin export to Australia

Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression

Optimi launches standardized microdose psilocybin products for clinical research

Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial

Optimi Health secures ibogaine supply

Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development

Optimi Health completes commercial production of psilocybin capsules

Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia

Optimi Health (NASDAQ: OPTH) (CSE: OPTI) Highlights Australia Psychedelic Therapy Expansion Following TGA Framework Update

Optimi Health reports expanded psychedelic-assisted therapy access in Australia

Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia

SRx Health Solutions and EMJX Invest in Recent IPO and Commercial-Stage Pharmaceutical Company of Psychedelics, Optimi Health Corp. (OPTH)

Optimi Health Shares Rise After Nasdaq Listing

MT Newswires Live

Optimi Health Debuts on U.S. Stock Market with Shares Opening Over 13% Lower

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:04 AM

NASDAQ TRADE HALT REASON NOT AVAILABLE AT 09:39 AM

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/OPTH/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OPTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OPTH\",,,,,undefined,":{"symbol":"OPTH","market":"US","secType":"STK","nameCN":"OPTIMI HEALTH CORP.","latestPrice":4.9,"timestamp":1789588800000,"preClose":5.07,"halted":0,"volume":59766,"hourTrading":{"tag":"盘后","latestPrice":4.99,"preClose":4.9,"latestTime":"19:47 EDT","volume":550,"amount":2741.43,"timestamp":1789602457870,"change":0.09,"changeRate":0.018367,"amplitude":0.018367},"delay":0,"changeRate":-0.03353057199211044,"floatShares":4256300,"shares":5725900,"eps":-1.393183,"marketStatus":"Closed","change":-0.17,"latestTime":"09-16 16:00:00 EDT","open":5.1,"high":5.1,"low":4.76,"amount":293557.62277799996,"amplitude":0.067061,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.393183,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":5,"adr":0,"listingDate":1779336000000,"exchange":"NASDAQ","adjPreClose":5.07,"preHourTrading":{"tag":"盘前","latestPrice":5.09,"preClose":5.07,"latestTime":"09:29 EDT","volume":1849,"amount":9638.1295726,"timestamp":1789565381058,"change":0.02,"changeRate":0.003945,"amplitude":0.102564},"postHourTrading":{"tag":"盘后","latestPrice":4.99,"preClose":4.9,"latestTime":"19:47 EDT","volume":550,"amount":2741.43,"timestamp":1789602457870,"change":0.09,"changeRate":0.018367,"amplitude":0.018367},"volumeRatio":0.463796},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OPTH\",,,,,undefined,":{"symbol":"OPTH","floatShares":4256300,"roa":"-16.06%","roe":"-54.36%","lyrEps":-0.832942,"volumeRatio":0.463796,"shares":5725900,"dividePrice":0,"high":5.1,"amplitude":0.067061,"preClose":5.07,"low":4.76,"week52Low":4,"pbRate":"2.23","psRate":"223.50","week52High":8.838,"institutionHeld":0,"latestPrice":4.9,"eps":-1.393183,"divideRate":0,"volume":59766,"delay":0,"ttmEps":-1.393183,"open":5.1,"prevYearClose":6.852,"prevWeekClose":4.42,"prevMonthClose":4.91,"prevQuarterClose":5.09,"fiveDayClose":4.35,"twentyDayClose":4.78,"sixtyDayClose":4.24},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OPTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-20","symbol":"OPTH","defaultRemindTime":1779283800000,"type":"split","dateTimestamp":1779249600000,"forFactor":30,"toFactor":1,"ratio":30}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OPTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OPTH\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OPTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OPTH","date":"2026-09-15","current":-3.517126,"percent":0.923077,"low":-11.793672,"twenty":-7.456144,"median":-6.82081,"eighty":-5.635054,"high":-5.019446,"avg":-7.005044,"sd":1.622216,"marketCap":27153774.08},"quantilePoints":[{"date":"2026-05-22","current":-11.007427,"twenty":-11.411781,"median":-11.260148,"eighty":-11.108516,"marketCap":31992926.41},{"date":"2026-05-29","current":-10.824906,"twenty":-11.51287,"median":-11.084647,"eighty":-10.895107,"marketCap":31420041.14},{"date":"2026-06-05","current":-8.174559,"twenty":-11.51287,"median":-11.007427,"eighty":-8.434895,"marketCap":31768506.5},{"date":"2026-06-12","current":-5.935667,"twenty":-11.161868,"median":-9.6299,"eighty":-7.029079,"marketCap":22898412.63},{"date":"2026-06-18","current":-6.352205,"twenty":-11.105708,"median":-8.200592,"eighty":-6.747916,"marketCap":24280961.81},{"date":"2026-06-26","current":-6.039801,"twenty":-11.024275,"median":-7.39355,"eighty":-6.143936,"marketCap":22991167.17},{"date":"2026-07-02","current":-7.705953,"twenty":-10.940035,"median":-7.39355,"eighty":-6.175176,"marketCap":29347825.96},{"date":"2026-07-10","current":-6.85205,"twenty":-10.852986,"median":-7.13842,"eighty":-6.289724,"marketCap":26129662.18},{"date":"2026-07-17","current":-7.268589,"twenty":-9.390899,"median":-7.029079,"eighty":-6.289724,"marketCap":27971005.98},{"date":"2026-07-24","current":-6.945772,"twenty":-8.309934,"median":-6.977012,"eighty":-6.49591,"marketCap":26627647.53},{"date":"2026-07-31","current":-6.783033,"twenty":-8.205799,"median":-7.013459,"eighty":-6.600045,"marketCap":26152601.3},{"date":"2026-08-07","current":-7.493132,"twenty":-7.987117,"median":-7.047996,"eighty":-6.633368,"marketCap":28848041.02},{"date":"2026-08-14","current":-7.100988,"twenty":-7.705953,"median":-7.047996,"eighty":-6.697931,"marketCap":27518925.16},{"date":"2026-08-21","current":-5.533835,"twenty":-7.660134,"median":-7.018666,"eighty":-6.258484,"marketCap":27727464.26},{"date":"2026-08-28","current":-5.691471,"twenty":-7.552096,"median":-6.95449,"eighty":-6.106447,"marketCap":28334629.62},{"date":"2026-09-04","current":-5.508946,"twenty":-7.484653,"median":-6.85205,"eighty":-5.789149,"marketCap":27574925.66},{"date":"2026-09-11","current":-5.143895,"twenty":-7.466671,"median":-6.831224,"eighty":-5.659943,"marketCap":25690469.3},{"date":"2026-09-15","current":-5.475759,"twenty":-7.456144,"median":-6.82081,"eighty":-5.635054,"marketCap":27153774.08}],"updateTime":1789612611299},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OPTH\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666594628","title":"Optimi Health to Start Phase 2 Trial of Psilocybin-Assisted Therapy for Major Depressive Disorder in H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2666594628","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666594628?lang=en_us&edition=fundamental","pubTime":"2026-09-10 22:57","pubTimestamp":1789052267,"startTime":"0","endTime":"0","summary":"Optimi Health  plans to start a phase 2 clinical trial to evaluate psilocybin-assisted therapy in individuals with major depressive disorder in H1 2027, the company said Thursday.Health Canada has approved the trial, which targets to enroll up to 200 participants across several sites in Canada, according to the statement. The trial's primary endpoint is the change in Montgomery-Asberg Depression Rating Scale total score from baseline, Optimi Health said.Price: 4.32, Change: -0.03, Percent Change: -0.69","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","OPTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666910405","title":"Optimi Health to initiate Phase 2 trial of psilocybin-assisted therapy for MDD","url":"https://stock-news.laohu8.com/highlight/detail?id=2666910405","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666910405?lang=en_us&edition=fundamental","pubTime":"2026-09-10 22:25","pubTimestamp":1789050337,"startTime":"0","endTime":"0","summary":"Optimi Health (OPTH) announces plans to initiate a multisite Phase 2 clinical trial evaluating psilocybin-assisted therapy for individuals with maj...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/optimi-health-to-initiate-phase-2-trial-of-psilocybin-assisted-therapy-for-mdd-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/optimi-health-to-initiate-phase-2-trial-of-psilocybin-assisted-therapy-for-mdd-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ABVC","GDOC","NVIB","IDNA","HYLG","MEDX","OPTH","PSIL","BK4007","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659414172","title":"Optimi Health establishes discretionary equity facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2659414172","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659414172?lang=en_us&edition=fundamental","pubTime":"2026-08-16 20:38","pubTimestamp":1786883902,"startTime":"0","endTime":"0","summary":"Optimi Health (OPTH) announced that it has entered into a common shares purchase agreement with Seven Knots, establishing an equity line of credit ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/optimi-health-establishes-discretionary-equity-facility-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/optimi-health-establishes-discretionary-equity-facility-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPTH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659211341","title":"Optimi Health Establishes Discretionary Equity Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2659211341","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659211341?lang=en_us&edition=fundamental","pubTime":"2026-08-15 04:55","pubTimestamp":1786740900,"startTime":"0","endTime":"0","summary":"VANCOUVER, British Columbia, Aug.  14, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) (the “Company” or “Optimi”), a commercial-stage pharmaceutical manufacturer of","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/14/3345637/0/en/optimi-health-establishes-discretionary-equity-facility.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4215","OPTH","VMRK","EQR","REZ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647303424","title":"Optimi Health completes psilocybin export to Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2647303424","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647303424?lang=en_us&edition=fundamental","pubTime":"2026-06-29 23:20","pubTimestamp":1782746418,"startTime":"0","endTime":"0","summary":"Optimi Health (OPTH) announced the completion of its latest export of 5mg psilocybin finished drug product to Australia, marking its third commerci...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/optimi-health-completes-psilocybin-export-to-australia-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/optimi-health-completes-psilocybin-export-to-australia-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647374792","title":"Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2647374792","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647374792?lang=en_us&edition=fundamental","pubTime":"2026-06-29 21:00","pubTimestamp":1782738000,"startTime":"0","endTime":"0","summary":"Optimi’s 5mg psilocybin capsules are prescribed in Australia for treatment-resistant depression.The export marks Optimi’s third commercial shipment since launching the 5mg psilocybin capsules in Septe","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/29/3318985/0/en/Optimi-Health-Completes-Psilocybin-Export-to-Australia-for-Patients-With-Treatment-Resistant-Depression.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644769468","title":"Optimi launches standardized microdose psilocybin products for clinical research","url":"https://stock-news.laohu8.com/highlight/detail?id=2644769468","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644769468?lang=en_us&edition=fundamental","pubTime":"2026-06-17 00:41","pubTimestamp":1781628061,"startTime":"0","endTime":"0","summary":"Optimi Health (OPTH) announced it has completed production of two microdose psilocybin finished drug products, formulated at 1 mg and 2 mg dosages....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/optimi-launches-standardized-microdose-psilocybin-products-for-clinical-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/optimi-launches-standardized-microdose-psilocybin-products-for-clinical-research-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642429206","title":"Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2642429206","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642429206?lang=en_us&edition=fundamental","pubTime":"2026-06-10 21:15","pubTimestamp":1781097300,"startTime":"0","endTime":"0","summary":"The shipment of naturally derived psilocybin, comprising both biomass and 5mg capsules, supports a planned Phase 2 clinical trial in the United Kingdom and was completed under export authorization fro","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/10/3309788/0/en/Optimi-Health-Completes-First-Export-of-Psilocybin-to-the-United-Kingdom-for-Phase-2-Clinical-Trial.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4211","BK4535","BK4503","API","UBCP","BK4023","OPTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641948107","title":"Optimi Health secures ibogaine supply","url":"https://stock-news.laohu8.com/highlight/detail?id=2641948107","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641948107?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:17","pubTimestamp":1780921074,"startTime":"0","endTime":"0","summary":"Optimi Health (OPTH) provided an update on its recently announced Ibogaine initiative. Optimi has secured naturally derived ibogaine from two sourc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/optimi-health-secures-ibogaine-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/optimi-health-secures-ibogaine-supply-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641811694","title":"Optimi Health Secures Ibogaine Supply and Commences Finished Drug Product Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2641811694","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641811694?lang=en_us&edition=fundamental","pubTime":"2026-06-08 20:00","pubTimestamp":1780920000,"startTime":"0","endTime":"0","summary":"Recent US executive order named ibogaine compounds among the psychedelic therapies prioritized for accelerated FDA review and expanded patient access Ibogaine is under investigation to treat PTSD, opi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/08/3308048/0/en/Optimi-Health-Secures-Ibogaine-Supply-and-Commences-Finished-Drug-Product-Development.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBI","BK4130","OPTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640394149","title":"Optimi Health completes commercial production of psilocybin capsules","url":"https://stock-news.laohu8.com/highlight/detail?id=2640394149","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640394149?lang=en_us&edition=fundamental","pubTime":"2026-06-02 22:57","pubTimestamp":1780412230,"startTime":"0","endTime":"0","summary":"Optimi Health (OPTH) announced the completion of a good manufacturing practice production run of its 5mg psilocybin finished drug product. The caps...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/optimi-health-completes-commercial-production-of-psilocybin-capsules-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/optimi-health-completes-commercial-production-of-psilocybin-capsules-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640910948","title":"Optimi Health Completes Commercial Psilocybin Production to Address Treatment-Resistant Depression in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2640910948","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640910948?lang=en_us&edition=fundamental","pubTime":"2026-06-02 19:30","pubTimestamp":1780399800,"startTime":"0","endTime":"0","summary":"Optimi’s 5mg psilocybin capsules are prescribed commercially for treatment-resistant depression in Australia, with additional product from the run earmarked for planned clinical trials in the United S","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/02/3305038/0/en/Optimi-Health-Completes-Commercial-Psilocybin-Production-to-Address-Treatment-Resistant-Depression-in-Australia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639671339","title":"Optimi Health (NASDAQ: OPTH) (CSE: OPTI) Highlights Australia Psychedelic Therapy Expansion Following TGA Framework Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2639671339","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639671339?lang=en_us&edition=fundamental","pubTime":"2026-05-30 01:00","pubTimestamp":1780074016,"startTime":"0","endTime":"0","summary":"Austin, Texas, United States, May 29th, 2026, FinanceWire This article has been disseminated on behalf of Optimi Health Corp. and may inc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/newswire/optimi-health-nasdaq-opth-cse-opti-highlights-australia-psychedelic-therapy-expansion-following-tga-framework-update?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/newswire/optimi-health-nasdaq-opth-cse-opti-highlights-australia-psychedelic-therapy-expansion-following-tga-framework-update?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TECS","FTEC","QID","MNQmain","QQQ","JEPQ","QQQE","OPTH","QQQY","TGA","TQQQ","TQQY","BK4213","GPIQ","NVIW.SI","NQmain","QYLG","QQQJ","QQQM","OPTI","NDX","SQQQ","QDTE",".IXIC","QQQA","IYW","ONEQ","PSQ","QLD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639678009","title":"Optimi Health reports expanded psychedelic-assisted therapy access in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2639678009","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639678009?lang=en_us&edition=fundamental","pubTime":"2026-05-29 21:55","pubTimestamp":1780062945,"startTime":"0","endTime":"0","summary":"Optimi Health (OPTH) acknowledged the final recommendations published by the Therapeutic Goods Administration following its targeted consultation o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/optimi-health-reports-expanded-psychedelic-assisted-therapy-access-in-australia-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/optimi-health-reports-expanded-psychedelic-assisted-therapy-access-in-australia-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OPTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639627723","title":"Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=2639627723","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639627723?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:30","pubTimestamp":1780057800,"startTime":"0","endTime":"0","summary":"Updated TGA recommendations broaden therapist eligibility, accept a wider range of treatment settings, and reinforce Australia's position as the world's leading commercial market for prescribed psiloc","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/29/3303582/0/en/Optimi-Health-Welcomes-Expanded-Psychedelic-Assisted-Therapy-Access-Under-Updated-Authorized-Prescriber-Framework-in-Australia.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPTH","BK4099","BK4588","03160","BK4604","TM","BK4555","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637339208","title":"SRx Health Solutions and EMJX Invest in Recent IPO and Commercial-Stage Pharmaceutical Company of Psychedelics, Optimi Health Corp. (OPTH)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637339208","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637339208?lang=en_us&edition=fundamental","pubTime":"2026-05-21 21:00","pubTimestamp":1779368400,"startTime":"0","endTime":"0","summary":"NORTH PALM BEACH, Fla., May  21, 2026  (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the \"Company\") and EMJ Crypto Technologies (\"EMJX\"), a digital-asset treasury operating pla","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/21/3299403/0/en/SRx-Health-Solutions-and-EMJX-Invest-in-Recent-IPO-and-Commercial-Stage-Pharmaceutical-Company-of-Psychedelics-Optimi-Health-Corp-OPTH.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","OPTH","SSI","SPCX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637821598","title":"Optimi Health Shares Rise After Nasdaq Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2637821598","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637821598?lang=en_us&edition=fundamental","pubTime":"2026-05-21 00:24","pubTimestamp":1779294282,"startTime":"0","endTime":"0","summary":"Optimi Health  shares rose 5.5% to $5.80 as they began trading Wednesday on the Nasdaq Capital Market after the company priced its underwritten public offering of 2.4 million shares at $6.25 each.The stock opened at $5.50 and reached a high of $6.40. The underwriter has an option to buy up to an additional 360,000 shares, the company said Wednesday in a statement.Gross proceeds from the offering, expected to close Thursday, are expected to be $15 million.Optimi plans to use the funds to expand production and distribution in its existing markets and to enter additional markets, including the US.Price: 5.80, Change: +0.30, Percent Change: +5.45","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NQmain","OPTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138369809","title":"Optimi Health Debuts on U.S. Stock Market with Shares Opening Over 13% Lower","url":"https://stock-news.laohu8.com/highlight/detail?id=1138369809","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138369809?lang=en_us&edition=fundamental","pubTime":"2026-05-21 00:14","pubTimestamp":1779293656,"startTime":"0","endTime":"0","summary":"On Wednesday, Optimi Health (OPTH.US) commenced trading on the U.S. stock market, with its share price opening more than 13% lower at $6.10. The IPO price was set at $7.05. Optimi Health is a...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636828021","title":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:04 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2636828021","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636828021?lang=en_us&edition=fundamental","pubTime":"2026-05-20 22:04","pubTimestamp":1779285878,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  VOLATILITY TRADING PAUSE AT 10:04 AM","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nAQN2LZSRH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636828535","title":"NASDAQ TRADE HALT  REASON NOT AVAILABLE AT 09:39 AM","url":"https://stock-news.laohu8.com/highlight/detail?id=2636828535","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636828535?lang=en_us&edition=fundamental","pubTime":"2026-05-20 21:39","pubTimestamp":1779284349,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALT  REASON NOT AVAILABLE AT 09:39 AM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nAQN2LZQMF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OPTH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}